Series introduction: drug repurposing for diseases

被引：1
作者：
Drummond, Iain A. [1 ,4 ]
Rovin, Brad H. [2 ]
Devuyst, Olivier [3 ]
机构：
[1] Mt Desert Isl Biol Lab, Davis Ctr, Bar Harbor, ME USA
[2] Ohio State Univ, Dept Internal Med, Div Nephrol, Columbus, OH USA
[3] Univ Zurich, Inst Physiol, Zurich, Switzerland
[4] Mt Desert Isl Biol Lab, Davis Ctr, 159 Old Bar Harbor Rd, Bar Harbor, ME 04609 USA
来源：
KIDNEY INTERNATIONAL | 2023年 / 103卷 / 05期
关键词：
drug repurposing; kidney disease;
D O I：
10.1016/j.kint.2023.03.006
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：812 / 812
页数：1
相关论文
共 6 条
  • [1] Dapagliflozin in Patients with Chronic Kidney Disease
    Heerspink, Hiddo J. L.
    Stefansson, Bergur V.
    Correa-Rotter, Ricardo
    Chertow, Glenn M.
    Greene, Tom
    Hou, Fan-Fan
    Mann, Johannes F. E.
    McMurray, John J. V.
    Lindberg, Magnus
    Rossing, Peter
    Sjostrom, C. David
    Toto, Roberto D.
    Langkilde, Anna-Maria
    Wheeler, David C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15) : 1436 - 1446
  • [2] Lasmiditan promotes recovery from acute kidney injury through induction of mitochondrial biogenesis
    Hurtado, Kevin A.
    Janda, Jaroslav
    Schnellmann, Rick G.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2023, 324 (01) : F56 - F63
  • [3] Drug Screen Identifies Leflunomide for Treatment of Inflammatory Bowel Disease Caused by TTC7A Deficiency
    Jardine, Sasha
    Anderson, Sierra
    Babcock, Stephen
    Leung, Gabriella
    Pan, Jie
    Dhingani, Neel
    Warner, Neil
    Guo, Conghui
    Siddiqui, Iram
    Kotlarz, Daniel
    Dowling, James J.
    Melnyk, Roman A.
    Snapper, Scott B.
    Klein, Christoph
    Thiagarajah, Jay R.
    Muise, Aleixo M.
    [J]. GASTROENTEROLOGY, 2020, 158 (04) : 1000 - 1015
  • [4] Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
    Packer, Milton
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Pocock, Stuart J.
    Carson, Peter
    Januzzi, James
    Verma, Subodh
    Tsutsui, Hiroyuki
    Brueckmann, Martina
    Jamal, Waheed
    Kimura, Karen
    Schnee, Janet
    Zeller, Cordula
    Cotton, Daniel
    Bocchi, Edimar
    Boehm, Michael
    Choi, Dong-Ju
    Chopra, Vijay
    Chuquiure, Eduardo
    Giannetti, Nadia
    Janssens, Stefan
    Zhang, Jian
    Juanatey, Jose R. Gonzalez
    Kaul, Sanjay
    Brunner-La Rocca, Hans-Peter
    Merkely, Bela
    Nicholls, Stephen J.
    Perrone, Sergio
    Pina, Ileana
    Ponikowski, Piotr
    Sattar, Naveed
    Senni, Michele
    Seronde, Marie-France
    Spinar, Jindrich
    Squire, Iain
    Taddei, Stefano
    Wanner, Christoph
    Zannad, Faiez
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15) : 1413 - 1424
  • [5] Targeting inflammation to treat diabetic kidney disease: the road to 2030
    Rayego-Mateos, Sandra
    Rodrigues-Diez, Raul R.
    Fernandez-Fernandez, Beatriz
    Mora-Ferna, Carmen
    Marchant, Vanessa
    Donate-Correa, Javier
    Navarro-Gonza, Juan F.
    Ortiz, Alberto
    Ruiz-Ortega, Marta
    [J]. KIDNEY INTERNATIONAL, 2023, 103 (02) : 282 - 296
  • [6] Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
    Torres, Vicente E.
    Chapman, Arlene B.
    Devuyst, Olivier
    Gansevoort, Ron T.
    Grantham, Jared J.
    Higashihara, Eiji
    Perrone, Ronald D.
    Krasa, Holly B.
    Ouyang, John
    Czerwiec, Frank S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (25) : 2407 - 2418
1